TrialVascular health and risk management2026
Taoren Honghua Jian Regulate NLRP3 Inflammasome of Coronary Artery Disease Patients: A Multi-Center, Double-Blind, Randomized Controlled Trial.
Min Du et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.